Corporate
GRAIL Stock Crashes 46% as Landmark Cancer Screening Trial Misses Primary Endpoint
Feb 20
You're signed outSign in or to get full access.
G
GRAIL (GRAL)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering GRAIL.